Navigation Links
Hill-Rom Reports Second Quarter Financial Results
Date:5/4/2009

January 2009, lower Liko margins associated with the valuation of acquired inventories and Liko integration costs. Adjustments in the prior year include costs associated with the spin-off of the funeral services business, primarily a stock modification charge and a loss on the extinguishment of debt. Unless otherwise indicated, amounts in the current quarter include the results of Liko, acquired on October 1, 2008.

Management Comments

"Consistent with our previous outlook, U.S. hospital and extended care customers continued to take a very cautious view toward capital spending as a result of recessionary concerns, yet our International and Post Acute businesses held steady. Our sales results also suggest that Hill-Rom is faring about the same as other capital equipment-intensive medical technology companies," commented Peter H. Soderberg, president and CEO of Hill-Rom. "In spite of the current softness in U.S. hospital capital equipment demand, we are maintaining our on-going multi-year growth strategy, while accelerating our efforts to reduce costs in both supply chain and other expense areas. We are pleased with the first six months of performance by our new Liko unit, and continue to integrate this business into our global and cross-continuum businesses as anticipated. We believe these efforts will position the company for future growth in anticipation of a return to more normalized customer demand."

Soderberg continued, "As a result of our manufacturing, service, and operating expense cost control initiatives, gross profit and operating profit margins, as adjusted, expanded both sequentially and year-over-year. We limited the decline in adjusted operating income to 2.2 percent, while only slightly reducing our investments in selling and R&D. While we cannot predict the timing of when hospitals and other providers will return to more normalized capital acquisition behavior, we should be wel
'/>"/>

SOURCE Hill-Rom Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Hill-Rom to Present at the Bank of America 2009 Health Care Conference
2. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Second Quarter Earnings Webcast
3. JCR and Hill-Rom Name First Nurse Scholar-in-Residence
4. Hill-Rom Announces Second Quarter 2009 Dividend
5. Hill-Rom to Present at the Canaccord Adams Musculoskeletal Conference
6. Hill-Rom Reports First Quarter Revenue Growth of 3.0 Percent to $352 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.23, an Increase of 15.0 Percent From the Prior Year
7. DRE Medical Equipment Now Sells Reconditioned Hill-Rom Hospital Beds
8. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 First Quarter Earnings Webcast
9. Hill-Rom Reports First Quarter Revenue of $350 Million and Announces Further Actions to Address Challenging Economic Environment
10. JCR, Hill-Rom Launch Nurse Safety Scholar-in-Residence Program
11. Hill-Rom Announces First Quarter 2009 Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2014)... July 12, 2014 “Critical Care ... New and Late-Stage Four-Factor PCCs and Recombinant Products ... the critical care market in the US, UK, ... report provides an estimation of market size for ... covers critical care indications that are being treated ...
(Date:7/12/2014)... As reported in this July 1st article ... the June 25th, 2014 Supreme Court ruling in Riley v ... It was also met with both cheers and jeers when ... seen from an individual privacy perspective, or a law enforcement ... now precedent which will require law enforcement officials to obtain ...
(Date:7/12/2014)... United Arab Emirates (PRWEB) July 12, 2014 ... another Los Angeles basketball legend is heading to the ... scorer and six-time champion will be in the UAE ... & Fitness Weekend in support of diabetes awareness. The ... an award-winning entertainment marketing and event management company based ...
(Date:7/12/2014)... 12, 2014 Praeclarus Press ... as a valuable new resource for women in need ... American women work away from their children. Today’s mothers ... benefits of breastfeeding, but often feel unsupported when it ... babies. With its evidence-based insights, and written by Nancy ...
(Date:7/12/2014)... Restore My Vision Today is a ... a couple boasting very impressive credentials on the field ... Today as a way to help consumers do without ... their respective patients’ treatments . , In ... trove of pertinent information relevant to eye care like:, ...
Breaking Medicine News(10 mins):Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 3Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 4Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 5Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 6Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 2Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 3Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 4Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 5Health News:Los Angeles Basketball Legend Headed to Dubai 2Health News:Los Angeles Basketball Legend Headed to Dubai 3Health News:Praeclarus Press Announces the Release of Working and Breastfeeding Made Simple by Nancy Mohrbacher, A Much Needed Resource For Today's Working Mothers 2Health News:Restore My Vision Today | Groundbreaking Book Reveals How To Restore Your Vision Without The Use of Glasses – Vinamy 2Health News:Restore My Vision Today | Groundbreaking Book Reveals How To Restore Your Vision Without The Use of Glasses – Vinamy 3
... first and only FDA-approved once-daily amoxicillin will be ... 7 MiddleBrook Pharmaceuticals, Inc. (Nasdaq: ... of Moxatag (amoxicillin extended-release) Tablets, 775mg, will begin ... hired over half of its 270-person field force ...
... Jan. 7 RRY Publications announced that the ... of stem cell company executives, scientists and investors, ... The Summit is an intensive one-day event where ... embryonic stem cells, the successful path to stem ...
... Neurosciences, Inc. ( OTC Bulletin Board: ILNS ), ... therapeutic agents for the treatment and prevention of ... granted a non-exclusive License to a top-tier global ... patent applications related to antibodies and methods of ...
... DTC Perspectives Inc., the leading DTC training, publishing and ... and DTC Perspectives Magazine , announced today the ... will serve the unmet needs of OTC Marketers, and ... to focus on the myriad of emerging issues OTC ...
... pleased to announce the selection of Clifford Brownstein as their new ... ... 2009 -- The National Association of Therapeutic Schools and Programs ... as their new Executive Director. , , , , ,Clifford ...
... Neurological Surgery, P.C., the largest private Neurosurgery practice on Long Island and ... treatment of children and adults afflicted with complex disorders of the brain ... States Army Reserve. , ... Great Neck, NY (PRWEB) January 7, 2009 ...
Cached Medicine News:Health News:MiddleBrook Pharmaceuticals to Launch Moxatag(TM) March 2009 2Health News:MiddleBrook Pharmaceuticals to Launch Moxatag(TM) March 2009 3Health News:MiddleBrook Pharmaceuticals to Launch Moxatag(TM) March 2009 4Health News:Stem Cell Product Commercialization Focus of Summit 2Health News:Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimer's Patents and Patent Applications 2Health News:Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimer's Patents and Patent Applications 3Health News:Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimer's Patents and Patent Applications 4Health News:Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company License to Certain Alzheimer's Patents and Patent Applications 5Health News:Crucial OTC Marketing Issues to be Addressed by New OTC Perspectives Division of DTC Perspectives, Inc. 2Health News:National Association of Therapeutic Schools and Programs Announces New Executive Director 2Health News:Neurological Surgery, P.C. of Long Island, NY Announces the Addition of Pediatric Neurosurgeon, Elizabeth M. Trinidad, M.D. 2Health News:Neurological Surgery, P.C. of Long Island, NY Announces the Addition of Pediatric Neurosurgeon, Elizabeth M. Trinidad, M.D. 3Health News:Neurological Surgery, P.C. of Long Island, NY Announces the Addition of Pediatric Neurosurgeon, Elizabeth M. Trinidad, M.D. 4
(Date:7/10/2014)... , July 11, 2014  Major advances ... of cancer are being highlighted in a three-day ... from 10-12 July, 2014.  Renowned national and ... share best practices and exchange knowledge on modern ... accurate and efficient. The Summit ...
(Date:7/10/2014)... , July 10, 2014  RESMED INC. (NYSE: ... fourth quarter and fiscal year ended June 30, 2014 results ... Exchange market close. A press release with ResMed,s results will ... company will host a webcast to discuss operating results and ... begin at 1:30 p.m. US Pacific Time and the live ...
(Date:7/10/2014)...  Decision Resources Group finds that while more ... are willing to prescribe Durata,s Dalvance (dalbavancin) and ... OPAT, approximately two-thirds of the respondents reported a ... inpatients. However, our findings indicate that nearly two-thirds ... OPAT following hospital discharge, and most are discharged ...
Breaking Medicine Technology:Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... Nov. 4, 2010 Valeant Pharmaceuticals International, Inc. (NYSE: ... the Company,s Board of Directors (the "Board") has declared ... (the "Special Dividend") that shareholders of record as of ... "Record Date") will be entitled to receive on December ...
... Cardiogenesis Corporation (OTCQB: CGCP), a leading developer of surgical ... disease, today reported financial results for its third quarter ... Revenue for the third quarter of 2010 was ... revenue of $2,134,000.  Gross margin was 84% for the ...
Cached Medicine Technology:Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan 2Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan 3Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan 4Cardiogenesis Reports Third Quarter 2010 Results 2Cardiogenesis Reports Third Quarter 2010 Results 3Cardiogenesis Reports Third Quarter 2010 Results 4Cardiogenesis Reports Third Quarter 2010 Results 5Cardiogenesis Reports Third Quarter 2010 Results 6
Available in Purple, orange, dark blue, yellow, gray, royal blue, green and light blue colors....
With a large white surface and a black X in the center, knockout really makes you look the heavyweight....
Icefire has ice crystals on the top of a cool blue iris....
This design features a solid red iris....
Medicine Products: